NZ-105 is primarily utilized in the field of medical research, particularly in the development of treatments for cardiovascular diseases. Its properties make it effective in inhibiting certain enzymes that are involved in the progression of heart-related conditions. Researchers have explored its potential in reducing inflammation and oxidative stress, which are key factors in the development of atherosclerosis and other vascular disorders. Additionally, NZ-105 has shown promise in preclinical studies for its ability to improve endothelial function, which is crucial for maintaining healthy blood vessels. Its application extends to experimental models where it is used to study the mechanisms of vascular protection and to evaluate its efficacy as a therapeutic agent. Further studies are ongoing to determine its safety and effectiveness in clinical settings.